Mitokinin's Series A Round

Mitokinin raised a round of funding on September 18, 2017.

Mitokinin is a biotechnology company focused on developing PINK1 targeted therapies for mitochondria-associated disorders, with particular focus on Parkinson's Disease and certain forms of mitochondri…

Articles about Mitokinin's Series A Round: